Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Market Cap ($372.92 Million)
Market Cap & Net Worth: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL)
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS market cap. Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (IS:GENIL) has a market capitalization of $372.92 Million (TL16.65 Billion) as of October 31, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #13545 globally and #93 in its home market, demonstrating a -12.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's stock price TL3.70 by its total outstanding shares 4500000000 (4.50 Billion).
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Market Cap History (2021–2026)
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS market cap history from 2021 to 2026. Data shows change from $1.45 Billion to $372.92 Million (-20.35% CAGR). Check Gen Ilac ve Saglik Urunleri Sanayi ve Ti stock price for real-time trading data and today's change.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see GENIL cash flow metrics for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.82x
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's market cap is 0.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
81.35x
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's market cap is 81.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.45 Billion | $2.50 Billion | $310.85 Million | 0.58x | 4.66x |
| 2022 | $5.00 Billion | $5.45 Billion | $1.08 Billion | 0.92x | 4.62x |
| 2023 | $4.65 Billion | $11.77 Billion | $656.32 Million | 0.40x | 7.09x |
| 2024 | $12.09 Billion | $14.74 Billion | $148.68 Million | 0.82x | 81.35x |
Competitor Companies of GENIL by Market Capitalization
Companies near Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS in the global market cap rankings as of October 31, 2026. See debt-free asset ratio of Gen Ilac ve Saglik Urunleri Sanayi ve Ti to understand what proportion of total assets are financed by equity.
Key companies related to Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2021–2026)
Market capitalization of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2021 to today. Between 2021 and today, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's market cap moved from $1.45 Billion to $ 372.92 Million, with a yearly change of -20.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL372.92 Million | -98.14% |
| 2025 | TL20.06 Billion | +65.83% |
| 2024 | TL12.09 Billion | +159.96% |
| 2023 | TL4.65 Billion | -6.88% |
| 2022 | TL5.00 Billion | +245.26% |
| 2021 | TL1.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $372.92 Million USD |
| MoneyControl | $372.92 Million USD |
| MarketWatch | $372.92 Million USD |
| marketcap.company | $372.92 Million USD |
| Reuters | $372.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV… Read more